Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects
暂无分享,去创建一个
M. Fasshauer | M. Stumvoll | P. Kovacs | M. Blüher | A. Beck‐Sickinger | N. Klöting | M. Schön | M. Kern | J. Heiker
[1] M. Fasshauer,et al. Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.
[2] Min-Seon Kim,et al. Circadian rhythm of serum vaspin in healthy male volunteers: relation to meals. , 2010, The Journal of clinical endocrinology and metabolism.
[3] W. Rathmann,et al. Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: Results from the MONICA/KORA studies. , 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[4] M. Fasshauer,et al. Serum Vaspin Concentrations in Human Obesity and Type 2 Diabetes , 2008, Diabetes.
[5] F. Ashcroft,et al. Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. , 2006, The Journal of clinical investigation.
[6] M. Fasshauer,et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. , 2006, Biochemical and biophysical research communications.
[7] Eijiro Watanabe,et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.